IRIS Accounts Production v24.3.2.46 04313155 Board of Directors 1.9.23 31.8.24 31.8.24 0 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh043131552023-08-31043131552024-08-31043131552023-09-012024-08-31043131552022-08-31043131552022-09-012023-08-31043131552023-08-3104313155ns15:EnglandWales2023-09-012024-08-3104313155ns14:PoundSterling2023-09-012024-08-3104313155ns10:Director12023-09-012024-08-3104313155ns10:PrivateLimitedCompanyLtd2023-09-012024-08-3104313155ns10:SmallEntities2023-09-012024-08-3104313155ns10:AuditExempt-NoAccountantsReport2023-09-012024-08-3104313155ns10:SmallCompaniesRegimeForDirectorsReport2023-09-012024-08-3104313155ns10:SmallCompaniesRegimeForAccounts2023-09-012024-08-3104313155ns10:FullAccounts2023-09-012024-08-310431315512023-09-012024-08-3104313155ns10:Director22023-09-012024-08-3104313155ns10:Director32023-09-012024-08-3104313155ns10:Director42023-09-012024-08-3104313155ns10:CompanySecretary12023-09-012024-08-3104313155ns10:RegisteredOffice2023-09-012024-08-3104313155ns5:CurrentFinancialInstruments2024-08-3104313155ns5:CurrentFinancialInstruments2023-08-3104313155ns5:Non-currentFinancialInstruments2024-08-3104313155ns5:Non-currentFinancialInstruments2023-08-3104313155ns5:ShareCapital2024-08-3104313155ns5:ShareCapital2023-08-3104313155ns5:RetainedEarningsAccumulatedLosses2024-08-3104313155ns5:RetainedEarningsAccumulatedLosses2023-08-3104313155ns5:NetGoodwill2023-09-012024-08-3104313155ns5:IntangibleAssetsOtherThanGoodwill2023-09-012024-08-3104313155ns5:LandBuildingsns5:ShortLeaseholdAssets2023-09-012024-08-3104313155ns5:PlantMachinery2023-09-012024-08-3104313155ns5:FurnitureFittings2023-09-012024-08-3104313155ns5:MotorVehicles2023-09-012024-08-3104313155ns5:ComputerEquipment2023-09-012024-08-3104313155ns5:NetGoodwill2023-08-3104313155ns5:NetGoodwill2024-08-3104313155ns5:NetGoodwill2023-08-3104313155ns5:LandBuildings2023-08-3104313155ns5:PlantMachinery2023-08-3104313155ns5:LandBuildings2023-09-012024-08-3104313155ns5:LandBuildings2024-08-3104313155ns5:PlantMachinery2024-08-3104313155ns5:LandBuildings2023-08-3104313155ns5:PlantMachinery2023-08-3104313155ns5:WithinOneYearns5:CurrentFinancialInstruments2024-08-3104313155ns5:WithinOneYearns5:CurrentFinancialInstruments2023-08-3104313155ns5:Secured2024-08-3104313155ns5:Secured2023-08-31
REGISTERED NUMBER: 04313155 (England and Wales)









OSLOND LIMITED
TRADING AS
GOLDCHEM PHARMACY

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 AUGUST 2024






OSLOND LIMITED (REGISTERED NUMBER: 04313155)
TRADING AS GOLDCHEM PHARMACY






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


OSLOND LIMITED
TRADING AS GOLDCHEM PHARMACY

COMPANY INFORMATION
FOR THE YEAR ENDED 31 AUGUST 2024







DIRECTORS: N Hooda
Mrs N Hooda
R Hooda
Miss M Hooda



SECRETARY: J Bandali



REGISTERED OFFICE: Station House
North Street
Havant
Hampshire
PO9 1QU



REGISTERED NUMBER: 04313155 (England and Wales)



ACCOUNTANTS: Morris Crocker
Chartered Accountants
Station House
North Street
Havant
Hampshire
PO9 1QU



BANKERS: HSBC Bank plc
94 East Street
Chichester
West Sussex
PO19 1HD

OSLOND LIMITED (REGISTERED NUMBER: 04313155)
TRADING AS GOLDCHEM PHARMACY

BALANCE SHEET
31 AUGUST 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - -
Tangible assets 5 61,995 82,446
61,995 82,446

CURRENT ASSETS
Stocks 378,437 357,016
Debtors 6 1,985,802 1,761,096
Cash at bank and in hand 407,411 264,212
2,771,650 2,382,324
CREDITORS
Amounts falling due within one year 7 854,173 864,551
NET CURRENT ASSETS 1,917,477 1,517,773
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,979,472

1,600,219

CREDITORS
Amounts falling due after more than one
year

8

(30,074

)

(35,468

)

PROVISIONS FOR LIABILITIES (7,988 ) (12,352 )
NET ASSETS 1,941,410 1,552,399

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 1,941,310 1,552,299
SHAREHOLDERS' FUNDS 1,941,410 1,552,399

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 August 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 August 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

OSLOND LIMITED (REGISTERED NUMBER: 04313155)
TRADING AS GOLDCHEM PHARMACY

BALANCE SHEET - continued
31 AUGUST 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 3 March 2025 and were signed on its behalf by:





N Hooda - Director


OSLOND LIMITED (REGISTERED NUMBER: 04313155)
TRADING AS GOLDCHEM PHARMACY

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2024

1. STATUTORY INFORMATION

Oslond Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents the value of goods delivered to or sold direct to customers during the year, net of discounts and value added tax.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2002, is being amortised evenly over its estimated useful life of twenty years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Short leasehold - straight line over 15 years
Plant and machinery - 25% on reducing balance
Fixtures and fittings - 20% on reducing balance
Motor vehicles - 25% on reducing balance
Computer equipment - 25% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Financial instruments
The company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable, loans from banks and other third parties and loans to related parties and investments in non-puttable ordinary shares.

Trade and other debtors
Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment

Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, deposits with banks and other short-term highly liquid investments and bank overdrafts. In the balance sheet, bank overdrafts are shown within borrowings or current liabilities.

Trade and other creditors
Short term trade creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method


OSLOND LIMITED (REGISTERED NUMBER: 04313155)
TRADING AS GOLDCHEM PHARMACY

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 AUGUST 2024

2. ACCOUNTING POLICIES - continued
Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company pays into a defined contribution pension scheme for selected employees. Contributions are charged to the profit and loss account in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - 47 ).

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 September 2023
and 31 August 2024 988,131
AMORTISATION
At 1 September 2023
and 31 August 2024 988,131
NET BOOK VALUE
At 31 August 2024 -
At 31 August 2023 -

OSLOND LIMITED (REGISTERED NUMBER: 04313155)
TRADING AS GOLDCHEM PHARMACY

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 AUGUST 2024

5. TANGIBLE FIXED ASSETS
Plant and
Land and machinery
buildings etc Totals
£    £    £   
COST
At 1 September 2023
and 31 August 2024 14,000 208,582 222,582
DEPRECIATION
At 1 September 2023 10,534 129,602 140,136
Charge for year 347 20,104 20,451
At 31 August 2024 10,881 149,706 160,587
NET BOOK VALUE
At 31 August 2024 3,119 58,876 61,995
At 31 August 2023 3,466 78,980 82,446

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 332,396 331,029
Other debtors 1,653,406 1,430,067
1,985,802 1,761,096

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts 5,381 5,236
Trade creditors 518,326 569,940
Taxation and social security 146,449 115,690
Other creditors 184,017 173,685
854,173 864,551

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2024 2023
£    £   
Bank loan 30,074 35,468

Amounts falling due in more than five years:

Repayable by instalments
Bank loan 7,139 13,101

OSLOND LIMITED (REGISTERED NUMBER: 04313155)
TRADING AS GOLDCHEM PHARMACY

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 AUGUST 2024

9. SECURED DEBTS

The following secured debts are included within creditors:

2024 2023
£    £   
Bank loan 35,455 40,704

The bank loan is secured by a fixed and floating charge on the assets of the company.

10. ULTIMATE CONTROLLING PARTY

The controlling party is the board of directors.